Nephrology
News
CKD Screening in all U.S. adults found cost effective
Modeling showed screening for and treating chronic kidney disease in U.S. adults was cost effective now that SGLT2 inhibitors are available.
News
SGLT2 inhibitors: Real-world data show benefits outweigh risks
“The importance of our paper is that it quantifies the absolute rate of events among routine care patients and may be used to inform shared...
News
Can SGLT2 inhibitors limit acute kidney injury in type 2 diabetes?
Contrary to the initial concerns that SGLT2 inhibitors might increase the risk of acute kidney injury, new data indicate that this complication is...
News
Fair access crucial for new diabetes/kidney disease drugs, say guidelines
A 2022 guideline for treating diabetes in people with chronic kidney disease highlighted the proven value of three underused drug classes and...
News
Dapagliflozin reduces hospitalizations in patients with CKD
A new analysis adds to a growing body of evidence supporting a range of positive benefits from dapagliflozin.
News from the FDA/CDC
FDA alert: ‘Substantial’ hypocalcemia risk with denosumab use in dialysis patients
The Food and Drug Administration sent an alert that it’s investigating an apparent link between the use of denosumab (Prolia) by patients on...
News
Promising new antibiotic emerges for treating UTIs
It would be the first new treatment in 20 years for UTIs, which affect more than half of women at least sometime in their lives.
Conference Coverage
Study sheds new light on RAS inhibitors’ role for advanced CKD
“The results of this trial will inform future clinical practice worldwide and guideline recommendations.”
News
Kidney function may help docs pick antiplatelet mix after stroke
Ticagrelor–aspirin compared with clopidogrel-aspirin reduced risk for recurrent stroke with no substantial increase in severe or moderate bleeding...
News
Goodbye ‘diabetes insipidus’, hello ‘AVP-D’ and ‘AVP-R’
Confusion with the term ‘diabetes mellitus’ ... has spurred proposed name change by an international panel representing major endocrinology...